Skip to main content
OpenTrials

Clinical trial condition

Post Essential Thrombocythemia Myelofibrosis

Explore clinical trials studying Post Essential Thrombocythemia Myelofibrosis. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Post Essential Thrombocythemia Myelofibrosis trial results

Completed

Panobinostat and Ruxolitinib in Primary Myelofibrosis, Post-polycythemia Vera-myelofibrosis or Post-essential Thrombocythemia-myelofibrosis

NCT01433445

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Novartis Investigative Site Paris, France
  • Novartis Investigative Site Villejuif, France
  • Novartis Investigative Site Magdeburg, Germany
  • Novartis Investigative Site Mainz, Germany
View Trial Details

Related conditions